AI and ML have ceased to be distant dreams of the future, becoming accessible tools that can revolutionize the way startups and small businesses operate. Photo via Getty Images

In today's fast-paced and technologically driven world, artificial intelligence and machine learning have emerged as transformative technologies that hold immense potential for startups and small businesses. While AI was once perceived as the domain of large corporations, it has become increasingly accessible, enabling startups and small businesses to leverage its capabilities to drive growth, enhance efficiency, and gain a competitive edge.

To start, AI is computer software that mimics the ways humans think in order to perform complex tasks, such as analyzing. ML is a subset of AI that uses algorithms trained on data to produce models that can perform complex tasks. The terms are often interchangeable.

Let’s explore how startups and small businesses can tap into the power of AI and ML right now to make a tangible impact on their business operations.

1. Streamlining Operations with Intelligent Automation

One of the primary advantages of AI and ML is their ability to automate repetitive and time-consuming tasks. Startups and small businesses can employ AI-powered chatbots to handle customer inquiries, freeing up valuable human resources and improving response times. Using chatbots in the past has been associated with a negative customer experience but is now more personal due to natural language processing (NLP) and offers the quick, convenient experience customers are looking for. ML algorithms can also automate data entry, data analysis, and report generation, reducing errors and boosting productivity. If you’re a business with regular customer interaction, you can implement a chatbot service. There are many chatbot service providers to explore with different price points.

2. Personalized Customer Experiences

AI and ML algorithms excel at processing vast amounts of data and extracting meaningful insights. By leveraging customer data, startups and small businesses can employ AI-driven recommendation systems to deliver personalized product recommendations, tailored marketing campaigns, and customized user experiences. This level of personalization enhances customer satisfaction, engagement, and ultimately, loyalty. For businesses with large amounts of data, you can implement a machine learning model into a basic application such as Excel. Just like chatbot service providers, there are many ML applications to choose from.

3. Enhanced Decision-Making with Predictive Analytics

Startups and small businesses often face the challenge of making informed decisions amidst uncertainty. AI and ML models can analyze historical data, identify patterns, and generate accurate predictions for various business aspects, such as demand forecasting, sales projections, and inventory management. Armed with these insights, business owners can make data-driven decisions that optimize their operations, reduce costs, and maximize profitability. Similar to creating a personalized customer experience, businesses can use ML to sift through large amounts of data, providing insights into trends not just with text, but also intention.

4. Improving Marketing and Sales Strategies

AI and ML have revolutionized marketing and sales strategies, offering startups and small businesses the ability to target the right audience with precision. Natural language processing (NLP) enables sentiment analysis, allowing businesses to gauge customer opinions and adapt their strategies accordingly. AI-powered tools can also automate lead generation, lead scoring, and customer segmentation, enabling businesses to focus their efforts on high-potential leads and optimize conversion rates. Many common CRM platforms incorporate AI with price points for small businesses.

5. Enhanced Cybersecurity and Fraud Detection

Startups and small businesses are not immune to cyber threats and fraudulent activities. AI and ML can fortify their security measures by analyzing network traffic patterns, detecting anomalies, and identifying potential threats. ML algorithms can detect fraudulent transactions in real-time, safeguarding businesses from financial losses. By deploying AI-driven cybersecurity measures, startups and small businesses can protect their data and ensure the trust of their customers.

6. Efficient Supply Chain Management

For startups and small businesses that rely on efficient supply chain management, AI and ML offer significant benefits. These technologies can optimize inventory levels, anticipate supply chain disruptions, and streamline logistics. By analyzing historical data and real-time information, AI algorithms can identify optimal delivery routes, reduce transportation costs, and minimize delays. This level of efficiency contributes to better customer service and higher customer satisfaction.

AI and ML have ceased to be distant dreams of the future, becoming accessible tools that can revolutionize the way startups and small businesses operate. It is crucial to recognize that successful implementation of these technologies requires careful planning, data quality, and ongoing monitoring. Startups and small businesses that embrace AI and ML now will position themselves as industry leaders, driving growth, and securing a competitive advantage in the dynamic business landscape of today and tomorrow.

------

Terence Low is the founder and CEO of Codistas IT Services.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”

Houston business mogul Tilman Fertitta acquires Caesars in $17.6B deal

Money Moves

Houston billionaire Tilman Fertitta may currently be serving as America’s ambassador to Italy, but his company is as busy as ever. Fresh off its move to revive the Houston Comets WNBA franchise, his company, Fertitta Entertainment, has announced a $17.6 billion deal to acquire Caesars Entertainment, Inc.

Speculation about the deal has been circulating since at least March, according to various media reports. The deal combines Fertitta’s well-known Golden Nugget casino brand with all of the properties in the Caesars’ portfolio, including Las Vegas hotels Caesars Palace, Harrah's, Paris Las Vegas, Planet Hollywood, Horseshoe, The LINQ Hotel, Flamingo, and The Cromwell.

Overall, the combined company will include 60 domestic casino resorts and gaming facilities; online gaming including sports betting, iCasino, and Caesar’s online poker platform; retail sports betting at over 200 third-party locations through the William Hill brand; and over 550 Fertitta Entertainment outlets, including more than 450 Landry's full-service restaurants across America. The companies will combine their loyalty programs, Caesars Rewards, Golden Nugget's 24 Karat Select Club, and Landry's Select Club.

The terms will see Caesars’ shareholders receive $31 per share. Fertitta Entertainment will also acquire approximately $11.9 billion of Caesars' outstanding debt.

The transaction will be financed through a combination of equity contributed by Fertitta Entertainment, assumed Caesars' debt, and new committed debt financing arranged by a group consisting of 10 banks. It is subject to approval by Caesars’ shareholders and government regulators.

Fertitta Entertainment is the Houston-based company behind a diverse array of hospitality businesses, including The Golden Nugget, The Post Oak Hotel, River Oaks District, the Kemah Boardwalk, and Houston’s Downtown Aquarium.

It also operates a number of prominent restaurant brands, including Mastro's Restaurants, Del Frisco's Double Eagle Steakhouse, Morton's The Steakhouse, The Palm, McCormick & Schmick's, Landry's Seafood House, The Oceanaire Seafood Room, and Saltgrass Steak House.

---

This article first appeared on CultureMap.com.

4 Houston-area institutions get $8M for cancer research facilities

fighting cancer

Cancer research capabilities in the Houston area just got an $8 million boost.

On Wednesday, May 20, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded $8 million in grants to institutions in Houston and Bryan for the creation or expansion of so-called “core” cancer research facilities.

“Core facilities provide shared access to advanced technology, equipment, and scientific expertise that may not be available at every institution,” CPRIT says. “These core facilities are vital to not only cancer research but also to the study of diseases beyond cancer.”

Houston-area recipients of these $2 million grants are:

  • A facility at the University of Texas Health Science Center for preclinical support of cancer researchers in Texas to evaluate new safe, effective drugs and drug combinations.
  • The Accelerator for Cancer Therapeutics, operated by Houston’s Texas Medical Center Foundation. The accelerator helps researchers and startups move innovative cancer treatments from the lab to clinical trials.
  • Rice University’s Genetic Design & Engineering Center in Houston. The center enables researchers to collaborate on studies of custom DNA for cancer treatment.
  • A facility at the Texas A&M University System’s Health Science Center in Bryan that aims to speed up the development of cancer therapies.

In addition to those grants, the University of Texas M.D. Anderson Cancer Center, Methodist Hospital Research Institute, Baylor College of Medicine, and Rice University shared $21 million to recruit cancer researchers from other institutions.

The largest of those grants—totalling $4 million—went to M.D. Anderson for the recruitment of renowned cancer researcher Andre Nussenzweig from the National Institutes of Health. His research focuses on how DNA damage and faulty DNA repairs lead to cancer.

Here are the totals for the other CPRIT grants awarded in the Houston area:

  • $12.8 million to Houston-based Indapta Therapeutics for the development of an off-the-shelf therapy that naturally kills cancer cells, combined with an immunity-targeting agent for a type of leukemia.
  • $11.1 million to MD Anderson, including $5 million for a statewide platform to improve long-term health outcomes in adolescents and young adults who survived cancer.
  • $8.4 million to Baylor College of Medicine, including $4.8 million for two training programs for cancer researchers.
  • $6.25 million to UT Health Houston, including $4 million for a biomedical informatics and genomics training program for cancer researchers.
  • $4.4 million to the Texas A&M Health Science Center’s Houston campus, including $2.4 million for a cancer therapeutics training program.
  • $2.75 million to Rice, including $250,000 for a study of ovarian cancer.
  • $2 million to Houston-based March Biosciences for the development of a targeted therapy for treating T-cell lymphoma.
  • $1.15 million to the University of Houston, including $900,000 for a platform for detection of lung cancer.
  • $900,000 to Texas A&M in Bryan to conduct clinical drug trials in rural and underserved communities around the state.
  • $800,000 to Houston- and Israel-based Xerient Pharma for the development of an oral form of a cell-protecting drug called amifostine to protect the upper GI tract from radiation damage during pancreatic cancer treatment.
  • $659,000 to Missouri City-based OmniNano Pharmaceuticals for the development of a two-drug combination to treat the most common form of pancreatic cancer.
  • $250,000 to the University of Texas Medical Branch at Galveston for a novel therapeutic to prevent colitis-related colorectal cancer.